Call Now Open
Oxford-Harrington Rare Disease Scholar Award
Lawrence Olanoff, MD, PhD is an expert in preclinical and clinical planning and strategy with more than 30 years of combined experience in clinical pharmacology and pharmaceutical development.
Special Advisor to the President for Corporate Relations, MUSC
Former President and COO, Forest Laboratories, Inc.
Former President and CEO, Celsion Corporation